Medication info

Uranthac Injection (Ranitidine Hydrochloride)

Prescription medicationSolutionOral · Intramuscular injection · Intravenous injectionExpired
Ingredient · strength
Ranitidine Hydrochloride›56mg / 1 ampoule
Manufacturer / importer
Hanin Pharmaceutical Co., Ltd.
Appearance
A clear solution that is colorless to pale yellow, or a brown ampoule or vial.
Packaging
1 ampoule (2 ml) × 50
Approval status
Expired

MFDS item code 198600665 · Notified 1986.08.22

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, etc.), treatment of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome
Who uses it
Adults · Children
Adult dosage
Adults Administer 50mg per dose of ranitidine 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of normal saline or glucose injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous infusion over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, an effect is generally observed within 1 week; switch to oral administration once it is possible to take the medicine orally. For premedication for anesthesia (prevention of Mendelson's syndrome), administer 50mg by intramuscular injection or inject slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Clinical studies in children have not been established.

Ingredients

Manufacturer
Hanin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, etc.), treatment of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcer
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • acute gastric mucosal lesion
View approved original text

This drug is used to treat gastric and duodenal ulcers, as well as gastrointestinal diseases such as Zollinger-Ellison syndrome and gastroesophageal reflux disease. Additionally, it is administered before anesthesia to prevent Mendelson's syndrome and is effective in treating postoperative ulcers. This drug can also help with peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions due to upper gastrointestinal bleeding. It is used to treat and prevent various digestive-related diseases.

Dosage and Administration

Adult dosage

Adults Administer 50mg per dose of ranitidine 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of normal saline or glucose injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous infusion over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, an effect is generally observed within 1 week; switch to oral administration once it is possible to take the medicine orally. For premedication for anesthesia (prevention of Mendelson's syndrome), administer 50mg by intramuscular injection or inject slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Clinical studies in children have not been established.

Precautions

This drug should not be used in patients who have had allergic reactions to this drug or any of its components. In patients with impaired kidney function, as this drug may remain in the body longer, the dosage should be reduced or the administration interval should be extended. This drug should be used with caution in patients with impaired liver function, a history of drug allergies, and elderly patients. Patients with a history of acute porphyria, a rare disease, should avoid this drug as it may worsen symptoms. This drug can rarely cause severe allergic reactions, such as anaphylactic shock; if any abnormal symptoms occur after administration, treatment should be stopped immediately and medical attention sought. If allergy symptoms such as hives, rash, difficulty breathing, or low blood pressure occur, the medication should be discontinued. Blood tests may show reduced white blood cells or platelets, so if symptoms such as general malaise, bleeding, or fever occur, consult a physician immediately. If symptoms of liver dysfunction or jaundice appear, the medication should be discontinued immediately and discussed with a healthcare professional. Rare side effects such as arrhythmias, vasculitis, and cardiac arrest may occur, so patients with heart disease should be cautious. Gastrointestinal symptoms such as constipation, nausea, and abdominal pain may occur, and if symptoms are severe, notify healthcare personnel. Neurological symptoms such as dizziness, drowsiness, headache, confusion, and hallucinations may occur; report any abnormal symptoms immediately. Hormone-related side effects such as gynecomastia and erectile dysfunction have been reported rarely, but causation is unclear. Serious muscle issues such as myalgia or rhabdomyolysis may occur rarely; consult healthcare professionals if muscle pain is severe. Skin reactions such as rashes, hair loss, and itching may occur. While using this drug, regular blood tests, liver function tests, and kidney function tests should be conducted, and if there is no therapeutic effect, alternative treatments should be considered. Elderly patients or those with chronic lung disease or diabetes may have an increased risk of pneumonia, so caution is advised. For high-dose intravenous use over five days, it's recommended to monitor liver enzyme levels daily. This drug should only be used when oral administration is not feasible or in emergencies, and it is preferable to switch to oral administration as soon as possible. This drug may interact with other medications, so inform healthcare providers if any other medications are being taken. Women who are pregnant or may become pregnant should carefully consider the benefits and risks before using this drug. Lactating women should also use this drug only when necessary, as it may be passed into breast milk. Safety in children has not been sufficiently established, so caution is necessary in its use. The urine protein test may yield false positive results, so other methods should be used for accurate testing. Overdose is rarely associated with specific toxic symptoms, but vomiting or gastric lavage may be necessary for appropriate emergency treatment. Intramuscular injection may cause pain or hardness at the injection site. Patients at risk of arrhythmias should be careful not to infuse this drug too quickly; intravenous injections should be administered slowly over at least 2 minutes. This drug may conceal symptoms of gastric cancer, so patients with gastric ulcers or new indigestion symptoms over the age of 40 should confirm malignancy before administration. Long-term use may affect the eyes, so caution should be exercised and eye examinations performed.

Side effects

Anaphylaxis shock, urticaria, angioedema, rash, fever, bronchospasm, hypotension, chest pain, vascular edema, granulocytopenia, elevated serum creatinine levels, leukopenia, thrombocytopenia, aplastic anemia, hypoplastic bone marrow, aplastic anemia, agranulocytosis, pancytopenia, acquired immune hemolytic anemia, eosinophilia, liver dysfunction, jaundice, hepatitis, bradycardia, atrioventricular block, tachycardia, vasculitis, cardiac asystole, constipation, nausea, vomiting, abdominal distension, abdominal pain, loss of appetite, diarrhea, acute pancreatitis, dizziness, drowsiness, convulsions, headache, heaviness in the head, insomnia, agitation, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorder, altered consciousness, hypertrophic muscle spasms, gynecomastia, excessive milk secretion, erectile dysfunction, decreased libido, arthralgia, myalgia, rhabdomyolysis, skin rash, erythema multiforme, alopecia, stomatitis, skin itching, acute interstitial nephritis, pain at the site of intramuscular injection, hardness at the site of intramuscular injection

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light, so it should be stored in a container that does not allow light to enter. It should also be kept at room temperature, away from excessive heat or cold.

Appearance and packaging

Appearance

A clear solution that is colorless to pale yellow, or a brown ampoule or vial.

Package unit

1 ampoule (2 ml) × 50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.